Korsuva: payments to doctors
Payments that named Korsuva as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $745K
- Providers
- 3,686
- Transactions
- 12,611
- Average per transaction
- $59
The per-transaction average — $59 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,686 providers the average total is $202, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Vifor Pharma, Inc. | $443,078 | 59.5% |
| Fresenius USA Marketing, Inc. | $301,868 | 40.5% |
| Fresenius USA Manufacturing, Inc. | $220 | 0.0% |